Anticoagulation management in hip fracture patients on warfarin [Injury 2005;36:1311-5]

Injury

Volumn 37, Issue 10, 2006, Pages 1029-1030

  Tharmarajah, P ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; BLOOD CLOTTING DISORDER; COST EFFECTIVENESS ANALYSIS; HIGH RISK PATIENT; HIP FRACTURE; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; MINIMALLY INVASIVE SURGERY; MITRAL VALVE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTICOAGULANTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; PRACTICE GUIDELINES; SURGICAL PROCEDURES, OPERATIVE; WARFARIN;

EID: 33748204033     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2006.06.121     Document Type: Letter

References (5)

1. Baglin T.P., Keeling D.M., and Watson H.G. Guidelines on oral anticoagulation (warfarin): third edition-2005 update. Br J Haematol 132 3 (2006) 277-285
2. Hanley J.P. Warfarin reversal. J Clin Pathol 57 11 (2004) 1132-1139
3. Paul B., Oxley A., Brigham K., et al. Factor II, VII, IX and X concentrations in patients receiving long term warfarin. J Clin Pathol 40 1 (1987) 94-98
4. Shields R.C., McBane R.D., Kuiper J.D., et al. Efficacy and safety of intravenous phytonadione (Vitamin K1) in patients on long-term oral anticoagulant therapy. Mayo Clin Proc 76 3 (2001) 260-266
5. White R.H., McKittrick T., Hutchinson R., and Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 122 1 (1995) 40-42